Necrobiotic xanthogranuloma associated with smoldering multiple myeloma: Satisfactory response to cyclophosphamide, dexamethasone, and thalidomide

5Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Necrobiotic xanthogranuloma is a rare chronic condition, belonging to the group C non-Langerhans cell histiocytoses, which is relevant due to the possibility of extracutaneous involvement and association with systemic diseases, particularly hematologic malignancies. The case reported here was only diagnosed after nine years of evolution and was associated with plasma cell dyscrasia. After treatment with cyclophosphamide, dexamethasone, and thalidomide, there was a reduction of cutaneous lesions and serum levels of monoclonal protein.

Cite

CITATION STYLE

APA

De Mello, R. B., & Do Vale, E. C. S. (2019). Necrobiotic xanthogranuloma associated with smoldering multiple myeloma: Satisfactory response to cyclophosphamide, dexamethasone, and thalidomide. Anais Brasileiros de Dermatologia, 94(3), 337–340. https://doi.org/10.1590/abd1806-4841.20198500

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free